Travelers — Deal Risk Assessment

2026-03-16 · Travelers Opal 2026 · Contracts Stage
Deal Snapshot
Account / Deal
Travelers — Travelers Opal 2026
Owner
Jen Oliver (AE) · Conor Leary (overlay)
Stage / Target Close
Contracts  2026-04-25 (pushed from 3/27 per 3/5)
Size / Strategic Importance
$309,000 base ($500K upside) · High (existing customer, FSI vertical, Opal in OKRs)
Key Champions
Betsey Shannon (marketing owner, highly engaged) · Dave Morgan (use case/ROI orchestrator, driving concurrent workstreams)
Signatory
Deborah Strong (Technology CFO) — signed 2025 renewal and upsell
Procurement Lead
Eric Drouin
Current Status (as of 2026-03-16)
Pricing presented 3/13: $618K/year (base platform + 2.5M credits + onboarding/FDE). Dave expressed "major league sticker shock" — benchmarking against internal AI group (Anthropic/OpenAI/Gemini direct agreements) and Atlassian AI costs. Yolanda raised underutilization risk; Matt offered Y1→Y2 credit rollover (needs CFO). Legal redlines actively exchanging — attorney meeting next week. March close dead; April 10 submission target for April 25 CIO/CFO review. Hartford in-person March 18 (Matt + Kevin). Two new risks added: R12 (sticker shock / raw LLM benchmarking) and R13 (credit underutilization / Y3 credit demand).
Total Risks
13
Known Risks
13
New Since 2/24
5
Play Code Legend
P1ELT exec bridge (C-suite ↔ C-suite)
P2SLT bridge (VP/Director ↔ VP/Director)
P3Back-channeling / political intel
P4Value / business outcomes workshop
P5Technical / architecture risk session
P6Commercial alignment session
P7On-site
P8Own internal business case structure
P9Customer-facing exec 1-pager
P10Internal exec briefing 1-pager
P11Pricing / term levers
Risk Register
ID Category Risk Evidence Impact Plays Owner & By When
R1 Paper Vendor approval process is opaque and slow — could take 1+ month
Known
  • 2/13 sync: "could take 1+ month with no visibility into steps."
  • A $0 POC started in October still isn't through architecture review.
  • Neither Conor nor Jen has visibility into approvers or status.
Critical path blocker. March 27 close impossible if vendor approval runs its historical pace. April now confirmed new target. P1 P2 P3 Jen — confirm Patrick West → Andrew Jaworski intro occurred; if not, re-engage
R2 Paper Dollar threshold may trigger higher/slower approval path
Known
  • 2/19 ROI session: Dave flagged dollar thresholds require different approval but did not disclose amounts.
  • 2/12: procurement flagged credit rollover as non-starter.
Unknown escalation path could add weeks. Combined with R1, creates compounding paper risk. Deal structure may need to be architected under threshold. P3 P6 P11 Conor/Jen — surface thresholds during pricing presentation
R3 Paper Legal redlines returning with unknown scope — timeline slipped twice
Known
  • 2/19: attorney completed redlining, returning "early this week."
  • 3/5: Yolanda revised to 2 weeks out — attorney "really, really busy." High-level guidance ~3/12; full redlines ~3/19.
  • Attorney already flagged technical question on AI infrastructure (Gemini).
  • Timeline has slipped twice from original estimate.
Extensive redlines = multi-week legal back-and-forth. AI-specific terms likely contentious for FSI. Each slip tightens April 8 submission window. P6 Jen — receive and triage redlines ~2026-03-19
R4 Value ROI calculation gated on Betsey's usage data
Known
  • 2/19: "Betsey's team providing usage data by Monday EOD."
  • Betsey's original scoring data was lost (save issue).
  • 3/5: Usage data received; 54% efficiency benchmark adopted. Mark's calculation: 31K hours, 16.3 FTEs, $2.47M savings. Dave/Betsey validating row-by-row (week of 3/9).
Partially mitigated — benchmark adopted and spreadsheet in progress. Row-by-row validation is the remaining gate before pricing presentation. Any delay cascades to April 8 submission. P4 Conor — confirm Dave/Betsey working session completed week of 3/9
R5 Commercial Credit rollover terms non-negotiable for Travelers procurement
Known
  • 2/12: "Dave flagged procurement team does not accept use-it-or-lose-it terms."
  • Procurement lead identified: Eric Drouin.
  • Signatory identified: Deborah Strong (Technology CFO) — signed 2025 renewal and upsell.
Could stall commercial negotiation at procurement stage even after business case is approved. Eric Drouin engagement needed with term alternatives ready. P6 P11 Jen/Conor — prepare term alternatives before Eric Drouin engagement
R6 Political Dave Morgan's interpersonal dynamics slow internal progress
Known
  • 2/13: "Dave is not forthcoming with details, his internal relationships may actually slow things down (people don't respond well to him)."
  • Betsey is "intimidated by Dave."
  • 3/5: Dave engaged methodically — positive signal, but his process-driven pace compounds timing risk.
Internal alignment and vendor approval acceleration depend on working around Dave's domain, not through him. P2 P3 Jen — Andrew Jaworski path bypasses Dave's bottleneck
R7 Paper FDE classification unresolved — may trigger separate SOW cycle
Known
  • 2/13: If FDE is classified as IT Services (not bundled in Advanced), Travelers requires their services SOW template, adding procurement delay.
  • Conor owns resolution via Suzanne.
Separate services classification = additional procurement review cycle on top of existing paper workstreams. Must resolve before pricing presentation. P6 Conor — confirm FDE resolution status before pricing presentation
R8 Timing Architecture review backlogged — 1-2 month estimate
Known
  • 2/12: "AI vendor approval timeline 1-2 months. Architecture review team backlogged with AI approvals."
  • Strong business case is the stated accelerator.
  • Dave is "following up" on status but no named contact (2/19).
Even with exec push, architecture review unlikely to compress below 3-4 weeks. April close at risk if not initiated immediately. P1 P2 Jen — exec acceleration via Jaworski/Patrick West; confirm status
R9 NEW 3/5 Commercial Yolanda pushing for POC/POT instead of direct commercial path
Known
  • 3/5: Yolanda floated POC as alternative path, citing "very new development" and pricing model not yet solidified.
  • Richard pushed back: "we have no hesitation on presenting pricing."
  • Yolanda asked team to discuss internally and share preferred path at next working session.
  • 3/13: Yolanda shifted from POC blocker to commercial negotiator — now negotiating terms (underutilization risk, monitoring period, Y3 credit). Positive engagement shift.
POC/POT risk partially mitigated by Yolanda's shift to commercial negotiation (3/13). Still monitor — could resurface if pricing impasse develops. P6 P11 Conor/Richard — hold firm on direct commercial path; Yolanda now engaging on terms
R10 NEW 3/5 Commercial Dave focused on minimum tier commitment, not total ROI
Known
  • 3/5: "Where I'm mostly focused is trying to figure out usage so we understand what we would potentially commit to with regard to usage volumes — what would our minimum tier be?"
Signals potential desire to start smaller than $309K scope. May need tiered pricing options or phased commitment structure to maintain value while meeting Dave's risk tolerance. P6 P11 Conor — prepare tiered commitment options alongside full proposal
R11 NEW 3/5 Commercial Module-dependent use case sequencing creates over-commitment perception
Known
  • 3/5: Dave flagged that not all modules can leverage Opal simultaneously — some use cases available in "next 3 months," others ramp later as CMS12 custom tooling (Kim's team) becomes available.
  • Scope includes 20% wildcard buffer beyond 36 identified use cases.
  • 90%+ of use cases confirmed on CMS12 — no CMS13 migration required.
Pricing a full 36-use-case scope from day 1 could lead Travelers to feel over-committed vs. actual day-1 value. Dave may use this to argue for smaller initial commitment. P6 P11 Conor — model phased/ramped commitment structure; sequence use cases into launch vs. 3–6 month tranches in pricing presentation
R12 NEW 3/13 Commercial $618K price triggers sticker shock — Dave benchmarking against raw LLM costs
Known
  • 3/13: Dave: "Major league sticker shock... not in a small way." Comparing Opal pricing for 12 users against Atlassian AI for 12,000 users.
  • Plans to benchmark with internal AI group using direct Anthropic/OpenAI/Gemini agreements.
  • Dave knows Opal uses Gemini — will compare credit pricing against raw token pricing.
If Travelers' AI group benchmarks Opal credits against raw token pricing, the orchestration markup will appear steep. Price competition is not against other products — it's against raw model access. Must reframe value of harness, tooling, FDE, and support. P6 P11 Conor — prepare orchestration value justification (harness, tooling, FDE, support) before Hartford 3/18; Jen arrange Shaf technical call
R13 NEW 3/13 Commercial Credit underutilization risk — Yolanda demanding contractual protection
Known
  • 3/13: Yolanda does not want to pay for unused capacity.
  • Matt offered Y1→Y2 rollover (requires CFO approval).
  • Yolanda countered with Y3 credit against final invoice.
New commercial concession required. Rollover + Y3 credit is beyond standard terms — needs CFO sign-off on Optimizely side. If denied, could stall procurement. P6 P11 Matt — take rollover proposal to CFO; Conor — prepare fallback positions
Mitigation Plays — Cross-Map
P1 — ELT Exec Bridge
Risks: R1, R8
Shafkat–Jim O'Brien meeting occurred ~late Feb (outcome TBC); Patrick West → Andrew Jaworski (status TBC)
P2 — SLT Bridge
Risks: R1, R6, R8
Andrew Jaworski engagement to bypass Dave's bottleneck and accelerate vendor approval. Confirm intro occurred.
P3 — Back-Channeling / Political Intel
Risks: R1, R2, R6
Visibility into vendor approval status, dollar thresholds, Dave dynamics
P4 — Value / Business Outcomes Workshop
Risks: R4, R10
Dave/Betsey row-by-row spreadsheet validation. Gates pricing presentation.
P6 — Commercial Alignment Session
Risks: R2, R3, R5, R7, R9, R11, R12, R13
Legal redlines triage, FDE classification, procurement term prep, POC counter, phased commitment structure, sticker shock response, underutilization terms
P11 — Pricing / Term Levers
Risks: R2, R5, R9, R10, R11, R12, R13
Credit rollover alternatives, dollar threshold awareness, tiered/phased commitment options, orchestration value justification, Y3 credit terms
Action Plan — Current Top Priorities (as of 2026-03-16)
1
[P6/P11] Prepare orchestration value justification before Hartford 3/18
Commercial New
Linked risks: R12
Why: Dave expressed "major league sticker shock" at $618K. Plans to benchmark Opal credits against raw Anthropic/OpenAI/Gemini token pricing via internal AI group. Hartford in-person 3/18 (Matt + Kevin) is the next face-to-face opportunity. Must reframe value: harness, tooling, FDE, support, governance — not raw token access.
2
[P11] Prepare rollover + Y3 credit terms for CFO approval
Commercial New
Linked risks: R13, R5
Why: Yolanda countered Matt's Y1→Y2 rollover with Y3 credit against final invoice. Both are beyond standard terms and require CFO sign-off on Optimizely side. If denied, procurement stalls. Prepare fallback positions.
3
[P6] Receive and triage legal redlines from Yolanda (~3/19)
Paper
Linked risks: R3
Why: Dave sent comments on counsel's red lines 3/12; attorney meeting next week. Full redlines expected ~3/19. Yolanda now engaging commercially (positive shift from POC push). Each day of delay compresses the April 10 submission window.
4
[P6] Counter POC/POT push — hold the line on direct commercial path
Commercial
Linked risks: R9
Why: Yolanda shifted from POC blocker to commercial negotiator (3/13) — positive signal. Risk partially mitigated but could resurface if pricing impasse develops. Continue framing scope clarity as the remaining gate, not a trial.
5
[P2] Confirm Andrew Jaworski introduction status and Jim O'Brien meeting outcome
Political Paper Timing
Linked risks: R1, R6, R8
Why: Both were in-flight as of 2/24. Jaworski intro is the single highest-impact unblocking action for vendor approval. Jim O'Brien meeting occurred ~late Feb but outcome not confirmed.
Action Plan — Carry-Over Priorities (from 2/24)
[P4] Confirm Betsey's usage data was delivered; unblock Mark's ROI calculation
Value Completed
Linked risks: R4
Status (per 3/5): Usage data received; 54% efficiency benchmark adopted; Dave/Betsey validating row-by-row (week of 3/9). Mark's value calculation complete at 54%: 31K hours, 16.3 FTEs, $2.47M savings.
?
[P4] Confirm Dave/Betsey row-by-row spreadsheet validation complete
Value TBC
Linked risks: R4, R10
Status: Targeted for week of 3/9. Pricing was presented 3/13 ($618K), suggesting validation may have completed. Confirm status.
?
[P1] Confirm Shafkat / Jim O'Brien exec meeting outcome
Paper Timing TBC
Linked risks: R1, R8
Status: Prep call was 2/25; Jim O'Brien meeting was ~2/27. Need to confirm outcome and whether vendor approval acceleration was discussed.
?
[P6] Resolve FDE classification (services vs. Advanced) via Suzanne
Paper Confirm Status
Linked risks: R7
Status: Originally due 2/26 via Suzanne. Confirm resolution status before pricing presentation.
Action Plan — Secondary Tasks
Internal Exec Support

Exec Escalation Required

Top Risks Requiring Exec Help (Max 3)
What We've Already Done to Mitigate
Specific Requests from ELT / SLT (Updated 2026-03-16)